US › Healthcare

Alterity Therapeutics Ltd (ATHE)

US · Healthcare · Biotechnology

$4.39-1.41%
Last close · 2026-08-04

Key statistics

Market cap
$80.0M
Forward P/E
0.0
P/B
2.12
Book value
$104.19
EPS (TTM)
$-0.56
52-week high
$5.89
52-week low
$2.66
50-day MA
$4.68
200-day MA
$3.96
Beta
-0.03

Analyst view

Analysts rate Alterity Therapeutics Ltd a buy (2 buy, 1 hold, 0 sell out of 3) with an average price target of $12.67.

Shareholding

Institutions
1.94%

Largest institutional holders

FundStake
Twin Lakes Capital Management, LLC0.77%
Greenleaf Trust0.34%
HB Wealth Management, LLC0.32%
Morgan Stanley - Brokerage Accounts0.32%
Citadel Advisors Llc0.11%
BNP Paribas Arbitrage, SA0.04%
GAMMA Investing LLC0.01%
Rhumbline Advisers0.01%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Alterity Therapeutics Ltd — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.